Abbott (ABT) Tops Q1 EPS by 2c; Boosts FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
BTIG Believes Abbot (ABT) May be Renegotating Terms of Alere (ALR) Deal; Affirms at 'Buy'
April 20, 2016 2:27 PM EDTBTIG affirms Abbot Labs (NYSE: ABT) at Buy with a price target of $45 and comments on Alere (NYSE: ALR) chatter following commentary from Abbott CEO Miles White earlier.
Analyst Dane Leone said: Comments from CEO Miles... More



